Position in INVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$37,125,823
+$14,697,624 QoQ
Shares Held
1,593,383
+42.0% QoQ
Ownership
2.16%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.77532081112953.ToString("F0")%
Shared 0.ToString("F0")%
None 0.22467918887047245.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. INVA ranks #64 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in INVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,125,823 | 1,593,383 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,428,199 | 1,121,971 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $21,981,431 | 1,204,462 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $29,542,263 | 1,470,496 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $24,567,853 | 1,355,094 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $30,219,847 | 1,741,778 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $22,435,785 | 1,161,874 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,931,265 | 910,443 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $13,231,520 | 868,210 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $16,547,360 | 1,031,631 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $13,221,871 | 1,017,850 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $12,978,769 | 1,019,542 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $5,565,329 | 494,696 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $9,531,586 | 719,365 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $12,463,369 | 1,073,503 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $16,596,158 | 1,124,401 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $16,406,632 | 847,888 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,526,174 | 436,300 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $5,550,426 | 332,162 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $1,879,048 | 140,123 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $9,503,667 | 795,286 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $14,130,014 | 1,140,437 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $13,339,184 | 1,276,477 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $24,880,778 | 1,779,741 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $17,178,325 | 1,460,742 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||